Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma.
about
Understanding natural herpes simplex virus immunity to inform next-generation vaccine designA macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacyVaricella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3Asymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein BAn important role for major histocompatibility complex class I-restricted T cells, and a limited role for gamma interferon, in protection of mice against lethal herpes simplex virus infection.Modulation of major histocompatibility class II protein expression by varicella-zoster virusNeutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro.Bovine herpesvirus 1 can infect CD4(+) T lymphocytes and induce programmed cell death during acute infection of cattle.Tegument-specific, virus-reactive CD4 T cells localize to the cornea in herpes simplex virus interstitial keratitis in humans.Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1.Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmissionRecent progress in herpes simplex virus immunobiology and vaccine researchClearance of HIV type 1 envelope recombinant sendai virus depends on CD4+ T cells and interferon-gamma but not B cells, CD8+ T cells, or perforin.Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virusDefining the herpes simplex virus-specific CD8+ T cell repertoire in C57BL/6 miceImmunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects.Immunodominant "asymptomatic" herpes simplex virus 1 and 2 protein antigens identified by probing whole-ORFome microarrays with serum antibodies from seropositive asymptomatic versus symptomatic individualsDiscovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling.High frequency of CD8+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpesCD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma.Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responsesAn adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs.Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D.Langerhans cells and viral immunity.Viruses and Langerhans cells.Human keratinocyte induction of rapid effector function in antigen-specific memory CD4+ and CD8+ T cells.Infection of murine keratinocytes with herpes simplex virus type 1 induces the expression of interleukin-10, but not interleukin-1 alpha or tumour necrosis factor-alpha.Human CD8+ CTL recognition and in vitro lysis of herpes simplex virus-infected cells by a non-MHC restricted mechanism.T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction.Tipping the scales of herpes simplex virus reactivation: the important responses are local.Herpes simplex virus-specific immune responses in subjects with frequent and infrequent orofacial recrudescences.Dysregulated expression of IFN-gamma and IL-10 and impaired IFN-gamma-mediated responses at different disease stages in patients with genital herpes simplex virus-2 infection.
P2860
Q26741484-69F9E9F0-8B23-426B-944C-1380FB8560E1Q27335068-4AE8591D-3FD6-45AF-8561-BEF02007C538Q28743826-5C19DB3E-3338-46D5-8EA4-DE8602D1F806Q30847945-45734556-03B8-44B8-B4C7-00BF18E87DEEQ33653142-47B1CE47-4324-4ACD-8266-89DCB76095E3Q33797830-3ACC6D4C-E3AB-4821-8F77-E11822316811Q33815811-F3175189-9A61-4963-8A08-B1ACCC930F22Q33820864-B07396C0-65CB-437E-A62C-1F31DC9F14CFQ33826410-D6DC76EF-1E04-4540-8721-0CA127D08AA0Q33842412-FC1E581D-19E0-400B-8462-C28F5A53FCBBQ33850188-7B3A5B85-4655-48B0-B3EE-D658D3D7ED5FQ33963713-E23EE0E2-EBCD-4573-BC1C-30611AE8B7A6Q34100215-25A29C75-DDEB-447B-8C89-62784B4AD9ADQ34529794-D956F9AA-E378-4BED-9928-A8926BF9D209Q35840599-2AC44D82-69B8-40FE-B466-2454E6D1DAF9Q35854117-FFC64DA5-1E0F-4CF4-AC53-C0A47527D90EQ35868029-7B06646A-0CC8-416F-AA36-04CCA6811D5BQ35868054-5774F1CA-084E-429E-AB5B-F99C73C33A3AQ35872807-B2F21777-C60A-4BBD-BFC5-B5B7020F0183Q36338436-72B7EC92-6831-4B2D-A550-70B5D5DAC0A1Q36555158-30836F73-D0E4-43C7-8F12-EE2E406F8E8BQ36585733-96E65EFE-032C-4607-BF70-A3161B1C2C73Q36759693-2F16FC94-9671-4167-AD6A-5508DB6D5A42Q36898071-C8DFE13F-9A9A-4EF1-AF5B-3B2C5543B4F3Q37268978-E47D1186-916D-4C9A-A3AD-466E320A2D33Q37743180-1B434414-2E60-4994-8FD6-96F0456B3ED6Q40132375-C3900BC2-D25B-46CB-901F-E4314AE3061BQ40744097-79D4678D-E275-4D3A-952E-3C961A9AAE8FQ40751313-FCC80E1C-F570-4732-8E7F-58E9A91D9CA0Q40993397-871A3682-2A04-4BEA-AE46-D4C54F19BBB4Q41740276-F4C4AF56-29EA-4CB9-BD7C-27C1AD71002DQ43548617-278DE883-CCD2-4A5D-9C23-06CBCC1DDF52Q45722867-4684BC3B-2C6A-4CC8-AA07-66DD4A266298
P2860
Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Herpes simplex virus protein t ...... treated with interferon-gamma.
@en
Herpes simplex virus protein t ...... treated with interferon-gamma.
@nl
type
label
Herpes simplex virus protein t ...... treated with interferon-gamma.
@en
Herpes simplex virus protein t ...... treated with interferon-gamma.
@nl
prefLabel
Herpes simplex virus protein t ...... treated with interferon-gamma.
@en
Herpes simplex virus protein t ...... treated with interferon-gamma.
@nl
P2093
P356
P1476
Herpes simplex virus protein t ...... treated with interferon-gamma.
@en
P2093
Cunningham AL
Mikloska Z
Penfold ME
P356
10.1093/INFDIS/173.1.7
P407
P577
1996-01-01T00:00:00Z